Medical researchers are constantly working to find new and more precise ways to treat the many health conditions and diseases found worldwide. Each and every discovery makes an impact on patients, which can ultimately be a life-changing experience. Skin Disease is no different, and new treatments often bring great benefit to patients that suffer from everything form acne breakouts, to more chronic Continue reading
Psoriasis is a chronic inflammatory disease affecting 7.5 million people in the United States. “It’s classified as an autoimmune disorder, meaning the bodies own immune system is creating an inflammatory response to itself,” says Dr. Kellie Reed, board certified Dermatologist at Sanova Dermatology. The severity of the condition can vary and affect activities of daily living even in mild forms. Continue reading
Hand eczema, sometimes referred to as hand dermatitis or dishpan hands, affects approximately 10 percent of the population. The condition is most common among those who are in frequent contact with chemicals or irritants, such as janitors, mechanics, hairdressers, and health care workers. Symptoms of Hand Eczema Eczema can cause the hands to become red, dry, and itchy. “Although the Continue reading
If you have eczema–especially if you haven’t found an effective treatment for your unbearably itchy skin–you may want to schedule an appointment with your dermatologist soon. For the first time in decades, there is a promising new treatment for eczema on the horizon. Dupilumab is being heralded as a breakthrough medication. The research that is being carried forward at the Continue reading
Plaque psoriasis is a chronic disease characterized by the appearance of patches of thick, red, and dry skin. While the disease shows itself on the surface of the skin, its origins are tied to the immune system. “Faulty signals from the immune system tell skin cells to grow too quickly, resulting in new skin cells forming in days rather than Continue reading
A new treatment for adult moderate-to-severe plaque psoriasis, Taltz (or ixekizumab), has been approved by the U.S. Food and Drug Administration. The new injection treatment was formulated by Eli Lilly & Co., is expected to be released by the end of the year. “Over 7 million people have been diagnosed with psoriasis, making it important to find a treatment that offers Continue reading
